Monthly Archives: June 2019

No Comments on Ask the CEO – 5

How safe is MP1032? And why is that so important to us?

Dr. Wolfgang Brysch
Dr. Wolfgang Brysch

Our Phase II clinical trial in psoriasis is almost completed. And we are especially interested in one question: Has the good safety profile from our previous studies been confirmed? Nobody wants avoidable side effects. But does it really make sense that we place so much emphasis on a good safety profile in the development of MP1032? 

When I started working in medical research, m...

Read more